Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 18Pancreatic Neoplasms 5Colorectal Neoplasms 4Biliary Tract Neoplasms 3Neoplasm Metastasis 2Breast Neoplasms 2Recurrence 1Rectal Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1Advanced Gastric Cancer 1Advanced Biliary Tract Cancer 1

Interventions

Oxaliplatin 5Capecitabine 5Cisplatin 4Paclitaxel 3Fluorouracil 3camrelizumab 2apatinib 2S 1 (combination) 2Leucovorin 2Docetaxel 2titanium silicide 1rucaparib 1relatlimab 1pazopanib 1linrodostat 1ezogabine 1endostar protein 1dacomitinib 1capivasertib 1Sunitinib 1Nivolumab 1Metabolic Networks and Pathways 1Irinotecan 1Ipilimumab 1Everolimus 1Epirubicin 1Electroporation 1Drug Therapy, Combination 1Drug Therapy 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Gastric Cancer × titanium silicide × Clear all
NCT00915382 2020-01-07

Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS

Asan Medical Center

Phase 3 Completed
625 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡